BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12007953)

  • 21. Results and patterns of failure in patients treated with adjuvant combined chemoradiation therapy for resected pancreatic adenocarcinoma.
    Hattangadi JA; Hong TS; Yeap BY; Mamon HJ
    Cancer; 2009 Aug; 115(16):3640-50. PubMed ID: 19514088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
    Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
    Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma.
    Pisters PW; Abbruzzese JL; Janjan NA; Cleary KR; Charnsangavej C; Goswitz MS; Rich TA; Raijman I; Wolff RA; Lenzi R; Lee JE; Evans DB
    J Clin Oncol; 1998 Dec; 16(12):3843-50. PubMed ID: 9850029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase I study of hyperfractionated radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic cancer.
    Ueno H; Okusaka T; Ikeda M; Tokuuye K
    Oncology; 2004; 67(3-4):215-21. PubMed ID: 15557781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pilot study in locally advanced unresectable pancreas carcinoma using a combination of accelerated radiotherapy and continuous infusion of 5-fluorouracil.
    Luderhoff EC; González González D; Bakker P
    Radiother Oncol; 1996 Sep; 40(3):241-3. PubMed ID: 8940751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Definitive chemoradiation therapy with capecitabine in locally advanced pancreatic cancer.
    Kim HS; Yi SY; Jun HJ; Lee J; Park SH; Lee JK; Lee KT; Lee KH; Choi DW; Choi SH; Heo JS; Park YS; Lim HY; Kang WK; Park HC; Lim DH; Park JO
    Anticancer Drugs; 2010 Jan; 21(1):107-12. PubMed ID: 19829097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose escalation of concurrent hypofractionated radiotherapy and continuous infusion 5-FU-chemotherapy in advanced adenocarcinoma of the pancreas.
    Zimmermann FB; Jeremic B; Lersch C; Geinitz H; Hennig M; Molls M
    Hepatogastroenterology; 2005; 52(61):246-50. PubMed ID: 15783041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes and tolerability of chemoradiation therapy for pancreatic cancer patients aged 75 years or older.
    Miyamoto DT; Mamon HJ; Ryan DP; Willett CG; Ancukiewicz M; Kobayashi WK; Blaszkowsky L; Fernandez-del Castillo C; Hong TS
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1171-7. PubMed ID: 19800182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiotherapy and continuous infusion 5-fluorouracil in patients with nonresectable pancreatic carcinoma.
    Boz G; De Paoli A; Innocente R; Rossi C; Tosolini G; Pederzoli P; Talamini R; Trovò MG
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):736-40. PubMed ID: 11597816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma.
    Myerson RJ; Valentini V; Birnbaum EH; Cellini N; Coco C; Fleshman JW; Gambacorta MA; Genovesi D; Kodner IJ; Picus J; Ratkin GA; Read TE
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1299-308. PubMed ID: 11483342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative radiation with concurrent 5-fluorouracil continuous infusion for locally advanced unresectable rectal cancer.
    Videtic GM; Fisher BJ; Perera FE; Bauman GS; Kocha WI; Taylor M; Vincent MD; Plewes EA; Engel CJ; Stitt LW
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):319-24. PubMed ID: 9788410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemoradiation and brachytherapy in biliary tract carcinoma: long-term results.
    Deodato F; Clemente G; Mattiucci GC; Macchia G; Costamagna G; Giuliante F; Smaniotto D; Luzi S; Valentini V; Mutignani M; Nuzzo G; Cellini N; Morganti AG
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):483-8. PubMed ID: 16242254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
    Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
    Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. External and intraoperative radiotherapy for resectable and unresectable pancreatic cancer: analysis of survival rates and complications.
    Nishimura Y; Hosotani R; Shibamoto Y; Kokubo M; Kanamori S; Sasai K; Hiraoka M; Ohshio G; Imamura M; Takahashi M; Abe M
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):39-49. PubMed ID: 9300738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of effectiveness of radiotherapy combined with cisplatin in patients with locally advanced pancreatic carcinoma.
    Okusaka T; Okada S; Tokuuye K; Wakasugi H; Saisho H; Ishikawa O; Matsuno S; Sato T; Sato K;
    Cancer; 2001 Apr; 91(7):1384-9. PubMed ID: 11283940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and tolerability of limited field radiotherapy with concurrent capecitabine in locally advanced pancreatic cancer.
    Jackson AS; Jain P; Watkins GR; Whitfield GA; Green MM; Valle J; Taylor MB; Dickinson C; Price PM; Saleem A
    Clin Oncol (R Coll Radiol); 2010 Sep; 22(7):570-7. PubMed ID: 20650619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative chemoradiation and intra-operative radiotherapy for pancreatic carcinoma.
    Macchia G; Valentini V; Mattiucci GC; Mantini G; Alfieri S; Digesù C; Deodato F; Trodella L; Doglietto GB; Cellini N; Morganti AG
    Tumori; 2007; 93(1):53-60. PubMed ID: 17455872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical resection after radiochemotherapy in patients with unresectable adenocarcinoma of the pancreas.
    Sa Cunha A; Rault A; Laurent C; Adhoute X; Vendrely V; Béllannée G; Brunet R; Collet D; Masson B
    J Am Coll Surg; 2005 Sep; 201(3):359-65. PubMed ID: 16125068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pilot study of preoperative continuous infusion 5-fluorouracil, external microwave hyperthermia, and external beam radiotherapy for treatment of locally advanced, unresectable, or recurrent rectal cancer.
    Anscher MS; Lee C; Hurwitz H; Tyler D; Prosnitz LR; Jowell P; Rosner G; Samulski T; Dewhirst MW
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):719-24. PubMed ID: 10837956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine versus 5-fluorouracil, a randomized controlled study.
    Li CP; Chao Y; Chi KH; Chan WK; Teng HC; Lee RC; Chang FY; Lee SD; Yen SH
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):98-104. PubMed ID: 12909221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.